Letter to the Editor: Postdiagnosis Aspirin Use Associated With Decreased Biliary Tract Cancer?
Hepatology
.
2022 Feb;75(2):494-495.
doi: 10.1002/hep.32170.
Epub 2021 Dec 6.
Authors
Hsin-Yu Hung
1
,
Chi-Chih Wang
2
3
,
James Cheng-Chung Wei
4
5
6
7
Affiliations
1
Department of EducationChung Shan Medical University HospitalTaichung CityTaiwan.
2
Division of Gastroenterology and HepatologyDepartment of Internal MedicineChung Shan Medical University HospitalTaichung CityTaiwan.
3
School of MedicineChung Shan Medical UniversityTaichung CityTaiwan.
4
Department of Allergy, Immunology, and RheumatologyChung Shan Medical University HospitalTaichung CityTaiwan.
5
Institute of MedicineChung Shan Medical UniversityTaichung CityTaiwan.
6
Graduate Institute of Integrated MedicineChina Medical UniversityTaichung CityTaiwan.
7
Department of Medical ResearchTaichung Veterans General HospitalTaichung CityTaiwan.
PMID:
34555199
DOI:
10.1002/hep.32170
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Inflammatory Agents, Non-Steroidal
Aspirin*
Biliary Tract Neoplasms* / diagnosis
Humans
Substances
Anti-Inflammatory Agents, Non-Steroidal
Aspirin